Finance News – Weightwatchers
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
WeightWatchers scraps business model to team up with anti-obesity drugs provider
The collaboration with a pharmaceutical company offering GLP-1 treatments represents a strategic move for the brand to diversify revenue streams and address declining market compet...
Read Full Article →WeightWatchers files for bankruptcy as fat-loss jabs boom
WeightWatchers is facing financial challenges due to increasing debt and intensified rivalry from the growing popularity of pharmaceutical treatments for weight reduction.
Read Full Article →Weight Watchers goes bankrupt even as it tries to ride the Ozempic boom
WeightWatchers has filed for bankruptcy due to over $1 billion in debt, aiming to restructure its finances while shifting focus toward weight loss medications such as GLP-1 treatme...
Read Full Article →WeightWatchers files for bankruptcy in a bid to cut its debt
The company facing persistent financial challenges disclosed intentions to initiate bankruptcy proceedings to restructure its obligations and collaborate with creditors in an effor...
Read Full Article →WeightWatchers files for bankruptcy after weight-loss drugs capsized industry
WW International sought Chapter 11 bankruptcy to restructure its debt following industry changes caused by the rapid rise of new obesity medications impacting its traditional reven...
Read Full Article →